Solid forms of tert-butyl (s)-2-((2s,3r) -1-amino-3-hydroxy-1-oxobu tan-2-yl)-1-oxo-2, 5-diazaspiro [3.4] octan e-5-carboxylate and methods of preparing them
WO2020263848A1
Processes and intermediates for producing diazaspiro lactam compounds
WO2020146878A1
Salt and crystalline forms of rapastinel
US2020368310A1
Treatment with nmda receptor modulators
WO2019094676A1
Methods of administration of nmda receptor agonists
CA3071269A1
Process and intermediates for synthesis of peptide compounds
CN108779148A
Method for synthesizing two pyrrolidines peptide compounds
CN106659763A
Methods of treating depression using nmda modulators
EP3171941A1
N-methyl-d-aspartate receptor modulators and methods of making and using same
AU2015280108A1
Methods of treating or ameliorating migraine
CN106535913A
Stable compositions of neuroactive peptides
AU2014342624A1
NMDA receptor modulators and prodrugs, salts, and uses thereof
KR20150110586A
Spiro-lactam nmda receptor modulators and uses thereof
KR20150110787A
Spiro-lactam nmda receptor modulators and uses thereof
US2014045943A1
Hydroxamic Acid Derivatives, Preparation and Therapeutic Uses Thereof
